Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > JHT x Phone Call
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1022)
•••
Comment by Nailbiter2on Jan 17, 2025 11:31am
27 Views
Post# 36408967

RE:JHT x Phone Call

RE:JHT x Phone CallI do have a question for your call.
Have the steps been successful in reaching full revocation?

I received a reply from IR that she would send me an update by EOD and that all is
moving along.

Kaddyshack wrote: Hey all!

I reached out to Rebecca/James via email yesterday and James replied that he would be happy to jump on a call to discuss my concerns with the company.

Does anyone have any REAL questions for him? I've been a shareholder for 4+ years now and told him I just want to know what the story is and why they have not been transparent to us.  Always the same 'its coming with partnerships' which we all know is smoke and mirrors as SZLS has been a downward sprial since that Q1 call years ago when he flubbed the Aristotle launch with no end in sight.

Frustrated SZLS Holder!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities